Baqsimi ® (glucagon) nasal powder


This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

How is Baqsimi™ (glucagon) nasal powder delivered?

Glucagon nasal powder is a dry nasal powder delivered via a ready-to-use nasal dosing device.



Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1

Baqsimi is a 3-mg glucagon dry nasal powder. It is delivered via a nasal dosing device that

  • is ready to use and requires no reconstitution
  • is a compact, portable, single-use, drug-device combination, and
  • does not require a person to inhale.1


1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.

Date of Last Review: November 10, 2021

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical